Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2005
10/06/2005WO2005093077A1 Plants having improved growth characteristics and method for making the same
10/06/2005WO2005093076A1 Method of separating precusror cells of liver cells, endothelial cells or hematopoietic cells from cell mass
10/06/2005WO2005093075A1 Peptide-based method for monitoring gene expression in a host cell
10/06/2005WO2005093074A1 Gas1 universal leader
10/06/2005WO2005093073A1 Exo-endo cellulase fusion protein
10/06/2005WO2005093072A1 Modified xylanases exhibiting improved expression
10/06/2005WO2005093071A1 Artificial actinomyces h+-pyrophosphatase gene and system for expressing the same in escherichia coli
10/06/2005WO2005093070A1 Recombinant herpesvirus and utilization of the same
10/06/2005WO2005093068A1 Novel protein and promoter
10/06/2005WO2005093067A1 Decoy nucleic acid to synoviolin gene promoter
10/06/2005WO2005093066A1 Marker gene for arthrorheumatism test
10/06/2005WO2005093065A1 Improved method of isolating nucleic acids
10/06/2005WO2005093064A1 Novel galectin 9 modification protein and use thereof
10/06/2005WO2005093063A1 Kit for solid cancer diagnosis and medicine for solid cancer therapy
10/06/2005WO2005093062A1 Genetic markers usable in breeding beer barley and utilization of the same
10/06/2005WO2005093061A1 METHOD OF ANALYZING PANCREATIC β-CELL AMOUNT AND/OR PANCREATIC β-CELL FUNCTION AND UTILIZATION THEREOF
10/06/2005WO2005093060A1 Process for producing 1,3-propanediol and/or 3-hydroxypropionic acid
10/06/2005WO2005093059A1 Primer and primer set for detecting and discriminating yeast, lactic acid bacterium and obligate anaerobe and detection/discrimination method using the same
10/06/2005WO2005093058A1 Genetic marker linked to gene locus involved in barley resistance to yellow mosaic disease and use thereof
10/06/2005WO2005093057A1 Truncated dance, dance complex and method of using these
10/06/2005WO2005093056A1 Process for producing dipeptide
10/06/2005WO2005093055A1 Transformed yeasts for detecting and measuring dioxins and methods for detecting, measuring and screening for dioxins employing the same
10/06/2005WO2005093054A1 Modified phytochrome
10/06/2005WO2005093053A1 Method and apparatus of automatically isolating and purifying nucleic acid
10/06/2005WO2005093052A1 Method for selectively separating and purifying rna and method for separating and purifying nucleic acid
10/06/2005WO2005093051A1 INACTIVE Ca2+/CALMODULIN-DEPENDENT PROTEIN KINASE IIα KNOCKIN ANIMAL AND KNOCKIN CELL OF THE SAME
10/06/2005WO2005093050A2 Cellulase fusion protein and heterologous cellulase fusion construct encoding the same
10/06/2005WO2005093040A1 Eukaryotic cells expressing phycocyanin
10/06/2005WO2005093036A2 Inhibitors of siderophore biosynthesis in fungi
10/06/2005WO2005092924A2 Rab9a, rab11a, and modulators thereof related to infectious disease
10/06/2005WO2005092920A1 Mussel bioadhesive
10/06/2005WO2005092919A1 Flowering time-controlling gene cog2 isolated from arabidopsis thaliana
10/06/2005WO2005092911A1 Method for separating and purifying nucleic acid
10/06/2005WO2005092443A1 Treatment of neurodegenerative diseases by the use of laptm4b
10/06/2005WO2005092394A1 siRNA CAPABLE OF INHIBITING EXPRESSION OF WT1 GENE AND USE THEREOF
10/06/2005WO2005092393A1 Micro rna inhibiting the expression of wt1 gene and utilization of the same
10/06/2005WO2005092383A1 Preventive/remedy for respiratory diseases
10/06/2005WO2005092379A2 Materials and methods for treatment of cancer
10/06/2005WO2005092374A2 Recombinant herpes simplex virus and uses therefor
10/06/2005WO2005092090A1 Obesity model animal and drug evaluation method using the same
10/06/2005WO2005092082A1 Method of transforming monocotyledonous seed
10/06/2005WO2005092069A2 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
10/06/2005WO2005092059A2 Compositions for use in identification of viral hemorrhagic fever viruses
10/06/2005WO2005092030A2 Methods of use of bcl-6-derived nucleotides to induce apoptosis
10/06/2005WO2005091992A2 Oligonucleotide compositions targeting egr-1 forcancer treatment
10/06/2005WO2005091777A2 Methods and materials relating to insulin growth factor-like (igfl) polypeptides and polynucleotides
10/06/2005WO2005091751A2 Novel gene associated with type 1 diabetes and methods of use
10/06/2005WO2005091716A2 Annexin ii and uses thereof
10/06/2005WO2005077977A3 Carcinoembryonic antigen fusions proteins and uses thereof
10/06/2005WO2005077126A9 Use of ppargamma specific inhibitors as anti-cancer therapeutics
10/06/2005WO2005072893A8 Functionalized colloidal metal compositions and methods
10/06/2005WO2005068630A8 Double-stranded rna for interference
10/06/2005WO2005063997A3 Maize metallothionein promoter
10/06/2005WO2005062820A9 Multi plasmid system for the production of influenza virus
10/06/2005WO2005059129A3 Adapter for coupling a substance which is to be coupled to a cell surface
10/06/2005WO2005054482A3 Nucleic acids having utility in seeds
10/06/2005WO2005054445A8 A method for isolating a self-renewing, multipotent slow-cycling cell
10/06/2005WO2005052588A3 Detection of protein interactions
10/06/2005WO2005052170A3 Gene silencing by using micro-rna molecules
10/06/2005WO2005049846A3 Mutant herpes simplex virus and use thereof in the treatment of squamous cell cancer
10/06/2005WO2005049838A3 Syk-targeted nucleic acid interference
10/06/2005WO2005034876A3 Use of cell lines to produce active therapeutic proteins
10/06/2005WO2005033316A3 Secretion of proteins from yeasts
10/06/2005WO2005027844A3 Dna vaccine compositions and methods of use
10/06/2005WO2005026388A3 The use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases
10/06/2005WO2005022167A3 Compounds that act to modulate insect growth and methods and systems for identifying such compounds
10/06/2005WO2005012316A3 Method for the production of multiply-unsaturated fatty acids in transgenic organisms
10/06/2005WO2005007877A3 Regulatable promoters for synthesis of small hairpin rna
10/06/2005WO2005002326A3 Generation of plants with improved drought tolerance
10/06/2005WO2004098499A3 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
10/06/2005WO2004094603A3 Transgenic mouse with simplified dh locus
10/06/2005WO2004080406A3 Therapeutic compositions
10/06/2005WO2004076618A9 Genetically modified non-human mammals and cells
10/06/2005WO2004041193A3 HUMAN TYPE II DIABETES GENE-Kv CHANNEL-INTERACTING PROTEIN (KChIP1) LOCATED ON CHROMOSOME 5
10/06/2005WO2004032877A3 Compositions, organisms and methodologies employing a novel human kinase
10/06/2005US20050223447 High artemisinin yielding plant genotype 'CIM-Arogya'
10/06/2005US20050223443 Inbred corn line PHCEG
10/06/2005US20050223442 Nucleic acid sequences coding nicotine demethylase for use as tool in identifying modulators of nornicotine concentration in cells
10/06/2005US20050223441 Methods for increasing the amount of protein in potato tubers
10/06/2005US20050223440 Tissue culture process for producing cotton plants
10/06/2005US20050223439 transgenic seeds/plants; horticulture; improved herbicide/insect/disease resistance
10/06/2005US20050223438 Functional plant, promoter to be used for producing the functional plant and method of using the same
10/06/2005US20050223437 Allene oxide synthase and divinyl ether synthase from the cyp74-enzyme family isolated out of physcomitrella patens, the nucleotide sequences that code these synthases, and method for producing pathogen-resistant plants
10/06/2005US20050223436 EPSP synthase highly tolerant to glyphosate
10/06/2005US20050223435 Methyl-D-erythritol phosphate pathway genes
10/06/2005US20050223434 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
10/06/2005US20050223433 Cobra gene and uses thereof
10/06/2005US20050223432 ODP2 promoter and methods of use
10/06/2005US20050223431 Gene over-/under-expression; cytochrome p450
10/06/2005US20050223430 Gntiii expression in plants
10/06/2005US20050223429 Stimulating root growth via introducing cytokinin oxidase protein sequences; point mutations
10/06/2005US20050223428 Methods for modulating plant growth
10/06/2005US20050223427 Modified polynucleotides for reducing off-target effects in RNA interference
10/06/2005US20050223426 Maize cellulose synthases and uses thereof
10/06/2005US20050223425 Methods for controlling plant pathogens using N-phosphonomethylglycine
10/06/2005US20050223424 Compositions and methods for altering amino acid content or proteins
10/06/2005US20050223423 Low maintenance turfgrass
10/06/2005US20050223422 Vector with a pormoter to modulate in vivo and in vitro transcription of a polynucleotide; with first and second nucleic acid molecules which are heterologous to each other
10/06/2005US20050223421 Artificial bidirectional promoter for activation of gene expression
10/06/2005US20050223420 Inducible heart attack animal model
1 ... 1934 1935 1936 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 ... 4023